KU Leuven Research & Development

KU Leuven Research and Development, known as LRD, is the technology transfer office of KU Leuven in Belgium, one of Europe’s most productive research universities. Operating from Leuven, LRD is structured as a startup studio rather than a traditional venture fund, which means its activity sits earlier than even most seed-stage investors and is focused on the formation of companies around KU Leuven research rather than backing already-incorporated startups.

The thesis spans biotech, medical devices and medtech, and health IT and healthcare software, with explicit AI focus including portfolio company EFFEX. LRD’s mandate is to convert KU Leuven research output into commercial entities, and the unit has built a long track record of producing spinouts across deep tech, life sciences, and digital health. The healthcare-relevant portfolio reflects KU Leuven’s research strengths in medical imaging, diagnostics, computational biology, and AI-native life science tooling.

Check sizes are below $250k and concentrated at Pre-Seed and Seed, which fits the studio’s role at the very earliest stages of company formation. That positioning means LRD typically participates alongside angels, regional public investors, and Belgian or European seed funds rather than leading institutional rounds on its own. Geographic focus is Belgium, with the KU Leuven ecosystem at the center, and portfolio companies typically attract international syndicates as they mature past initial formation.

The team integrates with KU Leuven’s broader research administration and provides scientific diligence, IP expertise, and the operational support needed to spin a research project into a company. Specific partner names are not provided in the source data, and the LinkedIn listing is unconfirmed, so founders should engage through KU Leuven LRD’s main channels.

The approach is studio-style and institutionally embedded. LRD is willing to participate in messy formation work, including IP licensing negotiations, founder role definition between academic and commercial responsibilities, and the slow operational build of a research-driven company. The firm is a strong fit for KU Leuven researchers building deep tech and life science companies who want institutional support from incorporation. Founders without a KU Leuven research connection or those needing institutional checks above $250k will need to look to other Belgian or European investors.